000			01374na a2200229 4500
003			H12O
005			20180417105937.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aGonzález Tomé, María Isabel _91354 _ePediatría
245	0	0	_aHIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations _h[artículo]
260			_bJournal of Adolescent Health, _c2011
300			_a48(1):100-102.
500			_aFormato Vancouver: Nso Roca AP, Larru B, Bellón JM, Mellado MJ, Ramos JT, González MI, et al. HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations. J Adolesc Health. 2011;48(1):100-2.
501			_aPMID: 21185531
504			_aContiene 10 referencias
520			_aThe use of atazanavir (ATV) in adolescents infected with human immunodeficiency virus was analyzed in this study. ATV morning plasma concentrations were determined during regular visits to the outpatient department. Results showed that bilirubin levels were higher among patients with higher ATV plasma concentrations (p = .018). Monitoring plasma levels of ATV could avoid toxicity in these patients.
710			_9446 _aServicio de Pediatría-Neonatología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc5557.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c5557 _d5557